Artin, Ben
Pitzer, Virginia E.
Weinberger, Daniel M.
Funding for this research was provided by:
NIH/NIAID (R01AI137093)
Article History
Received: 13 October 2020
Accepted: 7 May 2021
First Online: 21 May 2021
Competing interests
: Virginia E. Pitzer has received reimbursement from Merck and Pfizer for travel expenses to Scientific Input Engagements related to RSV vaccines. Daniel M. Weinberger has received consulting fees from Pfizer, Merck, GSK, and Affinivax for topics unrelated to this manuscript and is the Principal Investigator on a research grant from Pfizer on an unrelated topic. Ben Artin reports no relevant conflicts.